Clinuvel has good management, navigated regulatory affairs , have a good capital management strategy and their business structure and plan is solid (vertically integrated -full suite research, manufacture, regulatory affairs, sales and communication and marketing). Similar timeframe , different focus but seemingly light years ahead of SPL. I do own CUV but they don’t need cross promotion at $40 per share. I wish SPL would show an intention to improve on many fronts with or without current board and management.
Why are you here, page-17
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
